Is Medical Cannabis Addictive? UK Guide

Understanding Cannabis Use Disorder

• Cannabis use disorder (CUD) is a recognised clinical condition characterised by compulsive use, tolerance and withdrawal symptoms upon cessation
• Approximately 9% of cannabis users develop some form of dependence — a lower rate than tobacco (32%), alcohol (15%) or heroin (23%)
• The risk of dependence is higher with early-onset use (adolescence), heavy daily use and high-potency THC products
• Medical cannabis patients using moderate doses under clinical supervision represent a different risk profile from heavy recreational users

Contextualising the addiction risk honestly is important for patients considering treatment. The risk is real but substantially lower than for many commonly prescribed medications, and clinical supervision provides a layer of protection that recreational use does not.

Physical vs Psychological Dependence

• Physical dependence: the body adapts to regular cannabinoid exposure — stopping abruptly can cause withdrawal symptoms
• Cannabis withdrawal symptoms include: irritability, sleep disturbance, reduced appetite, anxiety, restlessness and mild sweating
• These symptoms typically begin within 24–48 hours of stopping and resolve within one to two weeks
• Psychological dependence: the habitual use of cannabis to manage mood or cope with stress — this is the more significant clinical concern for most patients

Physical withdrawal from cannabis is real but mild compared to opioid or benzodiazepine withdrawal. Patients and clinicians should not let this comparison minimise the experience — but it should put it in an accurate medical context.

Risk Factors for Developing Dependence

• Age of first use: starting in adolescence significantly increases lifetime risk
• Dose and potency: higher-THC products at higher doses over longer periods carry more risk
• Mental health: patients with anxiety, depression or PTSD who use cannabis to self-medicate are at higher risk of problematic use
• Personal or family history of addiction: a significant risk modifier for any substance

Medical cannabis prescribing in the UK specifically guards against some of these risk factors. Patients are typically adults, doses are controlled, products are standardised and monitoring is regular.

How Medical Prescribing Reduces Addiction Risk

• Prescribed doses are set and adjusted by a clinician — not driven by craving or self-escalation
• Regular follow-up appointments allow clinicians to identify early signs of problematic use patterns
• Products are dispensed in fixed quantities — preventing the stockpiling that sometimes occurs with self-purchased substances
• Patients can access support and alternative treatments if dependence concerns emerge

The clinical framework around medical cannabis prescribing is not a guarantee against dependence, but it provides meaningful safeguards that recreational use does not. Open communication with your prescribing team is the single most important protective factor.